Daiichi Sankyo is a global pharmaceutical company that develops and manufactures innovative medicines. The company was founded in 2005 and is headquartered in Tokyo, Japan. Daiichi Sankyo operates in more than 20 countries worldwide and has a workforce of over 15,000 employees. The company's research and development efforts focus on cardiovascular disease, pain management, and oncology. Daiichi Sankyo's products include treatments for hypertension, thrombosis, and acute coronary syndrome. The company also has a pipeline of drugs in development for the treatment of cancer and other diseases. Daiichi Sankyo is committed to improving the health and well-being of people around the world through the development of innovative medicines.